What is Exelixis's available for sale investments?

Exelixis (EXEL) reported available for sale investments of $1.27B in Q1 2026.

How has Exelixis's available for sale investments changed year-over-year?

Exelixis's available for sale investments decreased by 13.3% year-over-year, from $1.46B to $1.27B.

What is the long-term trend for Exelixis's available for sale investments?

Over 5 years (2020 to 2025), Exelixis's available for sale investments has grown at a -1.0% compound annual growth rate (CAGR), from $1.36B to $1.29B.

Exelixis EXEL Available for sale investments

Available for sale investments at other companies

Ionis PharmaceuticalsIONS

——

BridgeBio PharmaBBIO

——

AmgenAMGN

——

Merck & Co.MRK

——

Regeneron PharmaceuticalsREGN

——

Other financials

Income statement

See full

Revenue$610.8M+10.0%

Gross profit$590.9M+10.2%

Operating income$251.3M+34.5%

Net income$210.5M+31.9%

EPS (diluted)$0.79+43.6%

Balance sheet

See full

Cash & equivalents$226.2M+23.1%

Total debt$169.5M-9.4%

Total equity$1.9B-9.2%

Total assets$2.6B-8.6%

Cash flow

See full

Operating cash flow$251.8M+19.1%

CapEx$1.5M-48.9%

Free cash flow$250.3M+20.1%

Valuation

See full

Market cap$13.05B+10.1%

Enterprise value$12.99B+9.5%

P/E15.7×-2.8×

P/S5.5×+0.3×

Profitability

See full

Gross margin96.4%-0.3pp

Operating margin39.4%+6.3pp

Net margin35.1%+7.1pp

FCF margin38.6%+2.9pp

Returns & leverage

See full

Return on equity41%+10.8pp

Debt / equity0.1×0.0×

Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's available for sale investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exelixis's available for sale investments?: Exelixis (EXEL) reported available for sale investments of $1.27B in Q1 2026.
How has Exelixis's available for sale investments changed year-over-year?: Exelixis's available for sale investments decreased by 13.3% year-over-year, from $1.46B to $1.27B.
What is the long-term trend for Exelixis's available for sale investments?: Over 5 years (2020 to 2025), Exelixis's available for sale investments has grown at a -1.0% compound annual growth rate (CAGR), from $1.36B to $1.29B.